Evidence map›Paper›PMID 38918391›Full record

ArticleNature communications2024

SNM1A is crucial for efficient repair of complex DNA breaks in human cells.

Lonnie P Swift, B Christoffer Lagerholm, Lucy R Henderson, Malitha Ratnaweera, Hannah T Baddock, Blanka Sengerova, Sook Lee, Abimael Cruz-Migoni, Dominic Waithe, Christian Renz and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Lonnie P SwiftDepartment of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.ORCID 0000-0002-5026-2485
B Christoffer LagerholmWolfson Imaging Centre, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
Lucy R HendersonDepartment of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.ORCID 0000-0002-0142-5444
Malitha RatnaweeraDepartment of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.ORCID 0000-0003-0017-3801
Hannah T BaddockDepartment of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
Blanka SengerovaDepartment of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.ORCID 0000-0002-8082-5947
Sook LeeDepartment of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
Abimael Cruz-MigoniDepartment of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.ORCID 0000-0001-5937-4101
Dominic WaitheWolfson Imaging Centre, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
Christian RenzInstitute of Molecular Biology gGmbH (IMB), Mainz, Germany.ORCID 0000-0003-3164-3597
Helle D UlrichInstitute of Molecular Biology gGmbH (IMB), Mainz, Germany.ORCID 0000-0003-0431-2223
Joseph A NewmanCentre for Medicines Discovery, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-4488-0516
Christopher J SchofieldChemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-0290-6565
Peter J McHughDepartment of Oncology, MRC-Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom. peter.mchugh@imm.ox.ac.uk.ORCID 0000-0002-8679-4627

Funding

Cancer Research UK 24759Cancer Research UK (CRUK) CRUK/ A24759Wellcome Trust
6 · The paper itself

Abstract

DNA double-strand breaks (DSBs), such as those produced by radiation and radiomimetics, are amongst the most toxic forms of cellular damage, in part because they involve extensive oxidative modifications at the break termini. Prior to completion of DSB repair, the chemically modified termini must be removed. Various DNA processing enzymes have been implicated in the processing of these dirty ends, but molecular knowledge of this process is limited. Here, we demonstrate a role for the metallo-β-lactamase fold 5'-3' exonuclease SNM1A in this vital process. Cells disrupted for SNM1A manifest increased sensitivity to radiation and radiomimetic agents and show defects in DSB damage repair. SNM1A is recruited and is retained at the sites of DSB damage via the concerted action of its three highly conserved PBZ, PIP box and UBZ interaction domains, which mediate interactions with poly-ADP-ribose chains, PCNA and the ubiquitinated form of PCNA, respectively. SNM1A can resect DNA containing oxidative lesions induced by radiation damage at break termini. The combined results reveal a crucial role for SNM1A to digest chemically modified DNA during the repair of DSBs and imply that the catalytic domain of SNM1A is an attractive target for potentiation of radiotherapy.

Indexed as

DNA Breaks, Double-StrandedDNA RepairDNA Repair EnzymesExodeoxyribonucleasesCell Cycle ProteinsDNAHumansProliferating Cell Nuclear AntigenUbiquitinationCell Cycle ProteinsDCLRE1A protein, humanDNADNA Repair EnzymesExodeoxyribonucleasesPCNA protein, humanProliferating Cell Nuclear Antigen

Identifiers

PMID38918391
PMCPMC11199599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.